University of Michigan at Ann Arbor
RADIATION-DIAGNOSTIC/ONCOLOGY
Ann Arbor · United States
NIH R01 · 2024
ABSTRACT The development of techniques to generate functional, perfused blood vessel networks is essential for engineering of viable tissues as well as for the treatment of ischemic diseases. Pro-angiogenic growth factors have been used, either as a standalone therapy or in combination with cell-based techniques, to promote vascularization. Unfortunately, conventional approaches for delivery of pro-angiogenic growth factors have yielded disappointing results in clinical, therapeutic trials. This is because optimal growth factor combinations, concentrations, release kinetics, and spatial presentations are unknown. Thus, there is a need to develop translatable technologies for precisely…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.